Big Biotech’s Voracious Appetite
EVER SINCE President Bush limited federal funding of embryonic stem-cell research to existing cell lines, the mainstream media has obsessed about the perpetual political campaign to overturn his policy. But this is a mere dustup, a tempest in a teapot compared to the far more consequential story begging to be told of the radical and ambitious political agenda being pursued Read More ›